Deutsche Bank raises its price target on Hold-rated Amyris AMRS to $8, up $1, as it believes quarterly results aren't the only factor in share price performance.
Deutsche Bank says, "Large scale fermentation scale-up risk is the primary issue with the shares, and on this front, although expectations were really low going into the earnings call, we note that the recent round of financing is certainly an incremental positive as it allows the company to focus on execution. That said, we acknowledge that this is still a show me story and progress on key quarterly milestones would be critical for positive share price performance. Maintain Hold, $8 price target."
AMRS closed at $6 on Monday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in